OBJECTIVE: To get better recognition of central neurocytoma and diminish misdiagnosis. METHODS: A retrospective review identified 15 cases of central neurocytoma. All cases of central neurocytoma were analyzed for their clinical symptoms, pathologic changes, immunohistochemical staining, prognosis and differential diagnosis. Clinical follow up was performed. RESULTS: There were 8 males and 7 females aged 10-64 years (median 32.93 years). The most common presenting symptoms were those related to increased intracranial pressure (ICP), including headache (100%), papilledema (93%) and vomiting (80%). All tumors were located in the ventricular system. The tumors were composed of uniform cells with round nuclei and a fine chromatin pattern, and in some areas, small cells with perinuclear halo could be seen. In particular, the anuclear areas may have a fine fibrillary matrix (neuropil). Nuclear atypia and vascular proliferation appeared in two cases, respectively. Focal necrosis could be seen in one case. Immunohistochemical findings included expression of synaptophysin (15/15), neuron specific enolase (12/15) and glial fibrillary acidic protein (GFAP) (3/15). MIB-1 proliferation index ranged from 0.8-12.5%, and was more than 2% in 3 of 15 cases assessed. Follow-up information of 11 patients was available. CONCLUSIONS: Central neurocytoma has a favorable prognosis in general, but in some cases, the clinical course could be aggressive. Increase of GFAP positivity, proliferation index and vascular proliferation might suggest a more malignant process.
OBJECTIVE: To get better recognition of central neurocytoma and diminish misdiagnosis. METHODS: A retrospective review identified 15 cases of central neurocytoma. All cases of central neurocytoma were analyzed for their clinical symptoms, pathologic changes, immunohistochemical staining, prognosis and differential diagnosis. Clinical follow up was performed. RESULTS: There were 8 males and 7 females aged 10-64 years (median 32.93 years). The most common presenting symptoms were those related to increased intracranial pressure (ICP), including headache (100%), papilledema (93%) and vomiting (80%). All tumors were located in the ventricular system. The tumors were composed of uniform cells with round nuclei and a fine chromatin pattern, and in some areas, small cells with perinuclear halo could be seen. In particular, the anuclear areas may have a fine fibrillary matrix (neuropil). Nuclear atypia and vascular proliferation appeared in two cases, respectively. Focal necrosis could be seen in one case. Immunohistochemical findings included expression of synaptophysin (15/15), neuron specific enolase (12/15) and glial fibrillary acidic protein (GFAP) (3/15). MIB-1 proliferation index ranged from 0.8-12.5%, and was more than 2% in 3 of 15 cases assessed. Follow-up information of 11 patients was available. CONCLUSIONS:Central neurocytoma has a favorable prognosis in general, but in some cases, the clinical course could be aggressive. Increase of GFAP positivity, proliferation index and vascular proliferation might suggest a more malignant process.
Entities:
Keywords:
Central neurocytoma; MIB-1 labeling index; histopathology; immunohistochemistry; proliferation
Authors: L S Rajesh; Deepali Jain; B D Radotra; A K Banerjee; V K Khosla; R K Vasishta Journal: Indian J Pathol Microbiol Date: 2006-10 Impact factor: 0.740
Authors: Antonio De Tommasi; Pietro Ivo D'Urso; Claudio De Tommasi; Francesca Sanguedolce; Antonia Cimmino; Pasqualino Ciappetta Journal: Neurosurg Rev Date: 2006-09-05 Impact factor: 3.042
Authors: Fausto J Rodriguez; Renan A Mota; Bernd W Scheithauer; Caterina Giannini; Hilary Blair; Kent C New; Kevin J Wu; Dennis W Dickson; Robert B Jenkins Journal: Brain Pathol Date: 2008-08-15 Impact factor: 6.508
Authors: Shahed Tish; Ghaith Habboub; Jaes Jones; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan; Pablo F Recinos; Varun R Kshettry Journal: J Neurooncol Date: 2019-03-11 Impact factor: 4.130
Authors: Marta Navas; Rafael G Sola; Cristina V Torres; Sophia F Shakur; Rafael Manzanares; Carlos Gordillo; Jose A Jimenez Journal: Childs Nerv Syst Date: 2014-05 Impact factor: 1.475